D. Goldberg

发表

University of Dundee Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs ( EPIToPe )

Ross J. Harris, P. Donnan, A. Presanis, 2019 .

Shooting Up: Infections among people who inject drugs in the UK, 2018-an update, December 2019

P. Vickerman, S. Hutchinson, R. Wolstenholme, 2011 .

Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005‐2016: a national database linkage study

P. Hayes, H. Innes, S. Hutchinson, 2019, Alimentary pharmacology & therapeutics.

Shooting up: infections among injecting drug users in the United Kingdom 2006. An update: October 2007.

T. Rhodes, S. Hutchinson, J. McLauchlin, 2007 .

Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?

P. Hayes, H. Innes, S. Hutchinson, 2022, The American journal of gastroenterology.

Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts

M. Hickman, E. Robinson, A. Radley, 2023, BMC Public Health.

Excess liver‐related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care

P. Hayes, H. Innes, S. Hutchinson, 2011, Hepatology.

The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in Scotland.

S. Hutchinson, K. Dunleavy, R. Gunson, 2021, The International journal on drug policy.

Patients with hepatitis C (Redpath): a randomised controlled trial of telephone contact or offer of an incentive, in addition to a standard letter

E. Peters, S. Barclay, M. Priest, 2020, Journal of Hepatology.

Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making

P. Hayes, H. Innes, S. Hutchinson, 2022, Gastro Hep Advances.

HCV treatment as prevention in prison: Key issues

P. Vickerman, M. Hickman, N. Martin, 2014, Hepatology.

ADecadeofSpore- InfectionsAmonggDrug Users:Pronouncedn

D. Malouf, G. Harper, R. Garofalo, 2012 .

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

R. Peeling, J. Ward, Rakesh Aggarwal, 2019, The lancet. Gastroenterology & hepatology.

Hepatitis C: who is at risk and how do we identify them?

D. Goldberg, D. Goldberg, D. Goldberg, 2004, Journal of viral hepatitis.

Hepatitis C action plan for Scotland: phase II (May 2008-March 2011).

S. Hutchinson, J. Dillon, D. Goldberg, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study

M. Alavi, P. Hayes, G. Dore, 2018, Journal of viral hepatitis.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

R. Peeling, Rakesh Aggarwal, S. Taylor-Robinson, 2019, The lancet. Gastroenterology & hepatology.

Prioritization of HCV treatment in the direct-acting antiviral era: An evaluation.

G. Dore, P. Vickerman, M. Hickman, 2017 .

Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect‐acting antiviral era

M. Alavi, P. Hayes, H. Innes, 2017, Journal of viral hepatitis.

The growing contribution of hepatitis C virus infection to liver-related mortality in Scotland.

S. Bird, S. Hutchinson, C. Robertson, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.